Obsessive Compulsive Disorder

Epidemiology

Comorbidity

OCD and Tic Disorder

OCD and Depression

OCD and Other Anxiety Disorders

OCD and Phobia

OCD and OCPD

OCD and Schizophrenia

Course and Prognosis

Etiology

Specific Clinical Response

Serotonin Antagonists

Pharmacological Challenges

Dopamine

Immune Factors

Brain Imaging Studies

Genetics

Other Biological Data

Behavioral Factors

Psychosocial Factors

Treatment of OCD

Efficacy of Serotonergic vs Adrenergic Antidepressants

Long Term Treatment of OCD

Drug Dosage

Psychological Approaches

Treatment Resistant OCD

Switching Medications

Augmentation

Risperidone

Pindolol

Other Options

Intravenous Clomipramine

Monoamine Oxidase Inhibitors

Last-line Therapies

Overcoming Anxiety (Home) > Obsessive Compulsive Disorder > Long Term Treatment of OCD

Long Term Treatment of OCD: Alternative, Medication, Condition and Assessment

It has been demonstrated that the length of treatment should be considerable and that most patients relapse after premature discontinuation. Pato et al. (1988) reported that 16 out of 18 patients with OCD relapsed within seven weeks after discontinuing CMI, although some had been treated for more than a year (mean= 10.7 months). All patients regained therapeutic effects when CMI was reintroduced. Leonard et al. (1991) examined the effect of CMI substitution during long-term CMI treatment in 26 children and adolescents with OCD (mean duration of treatment was 17 months). Half of the patients were blindly assigned to two months of desipramine (DMI) treatment, and then CMI was reintroduced. Almost 90% relapsed during the twomonth substitution period in comparison with only 18% of those kept on CMI. It seems advisable for OCD patients to be maintained on antiobsessive medications for more than a year before a very gradual attempt to discontinue the treatment is carried out. The required maintenance dose in OCD is also unclear. In a study that examined this issue, investigated the effect of dose reduction in 30 patients previously treated successfully with CMI or fluoxetine. Patients were randomized to receive the same drug dosage, to receive a reduced dose or a very reduced dose. There was no difference found between the groups during the 102 days of the study.




More Articles
1. Yoga: Anti Depression Agent Role
Yoga in the Role of Anti Depression Agent Most of the health problems that people face today are stress related. You live a life of [...]

2. Age of Onset of Social Phobia:Age Anxiety Disorders
Age of Onset of Social Phobia: Anxiety Disorders The onset of social phobia generally occurs early in childhood or in adolescence, between [...]

3. Demoralisation
Demoralisation Some patients with PD or PD/agoraphobia (about 30%) develop feelings of sadness, guilt, anhedonia. Generally, this state may be considered as psychological demoralization [...]

4. Pharmacological Treatment of Ocd
The Pharmacological Treatment of Ocd Since the early 1980s, several potent serotonin re-uptake inhibitors (SRIs) have been studied extensively in OCD. Aggregate [...]


ADD YOUR LINK HERE

Bookmark This Page:

Add to Favorites

Add to Del.icio.us

Send to a Friend

Resources:

Alternative Health

Anxiety

Depression

Health

Mental Health

Nutrition

Psychotherapy

Self Help

© Overcoming Anxiety .org | SITEMAP | Resources

RSS Feed

About Us | Contact Us | Link to Us

Terms of Service, Privacy Policy and Disclaimer